CHARLES MCWILLIAMS: Open Payments
NPI 1295221166 · DUNCANVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$654 in 36 payments from 10 companies in 2025. Trend: 2023 $442 · 2024 $480 · 2025 $654
Food & beverage: $654
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 14 | $224 |
| Novo Nordisk Inc | 4 | $84 |
| AstraZeneca Pharmaceuticals LP | 5 | $81 |
| Abbott Laboratories | 3 | $69 |
| PFIZER INC. | 3 | $60 |
| GlaxoSmithKline, LLC. | 2 | $49 |
| Amgen Inc. | 2 | $32 |
| Exact Sciences Corporation | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Corcept Therapeutics | 1 | $17 |
Products named: JARDIANCE, TRELEGY ELLIPTA, FREESTYLE LIBRE, AIRSUPRA, MOUNJARO, PAXLOVID, REPATHA, BREZTRI.
Industry payments across TX — which companies pay providers there.
